Cardiac safety services refer to offering services related to heart safety monitoring by giving the required support and help to design clinical trials and other research. According to BlueQuark the Global Cardiac Safety Services Market is expected to grow considerably during the forecasted period. Factors such as advancements in the clinical trial field have increased the number of clinical trials, which is expected to drive the cardiac safety services market in the forecasted period. Further, the rising ageing population and sedimentary lifestyle among millennials are increasing the demand for healthcare solutions, which is expected to drive the cardiac safety services market in the forecasted period. Furthermore, pharmaceutical companies are increasingly outsourcing research activities to academic organizations, which is expected to drive the cardiac safety services market in the forecasted period. However, the massive cost of services and lack of skilled persons are expected to restrain the cardiac safety services market in the forecasted period.

The ECG/ Holter measurement services segment held the largest market. The large share of this fragment can be accredited to the low cost of ECG/Holter services and rigorous regulations for drug safety, increasing research & development activities to develop effective and innovative drugs. A Holter monitor is a battery-operated portable ECG device that a patient can wear for 24 to 48 hours, which continuously records heart activity (electrocardiogram) and monitors the heart rhythm. This mobile device provides several advantages over traditional ECG devices, such as fewer leads and the patient is free to move and go around their usual daily routines, increasing its usage among patients and physicians. Older patients have more prominent anatomical changes and more vital functional impairment during heart diseases, and cardiovascular changes that occur with ageing make acute coronary syndrome (ACS) more likely to occur. They may make diagnosing and treating it more complex. It happens because large arteries become stiffer in older people. The heart muscle often works harder but pumps less effectively. The rise in the number of older adults and the rising incidence of cardiovascular disorders are blamed for the ECG Holter's expansion. According to data declared by Health System Tracker, heart disease is the top principal of mortality in the US. These reasons make instant heartbeat detection and constant heart rate monitoring equipment necessary. The healthcare system has used ECG monitoring devices to look for abnormalities in cardiac activity. Hence, the increasing complications of cardiovascular diseases with old age are expected to boost the adoption of ECG/Holter measurement services.

North America is expected to account for a significant share of cardiac safety services during the forecasted period, owing to the rise in geriatric patients and the high prevalence of cardiovascular diseases. Due to the surging number of elderly patients and the high incidence of cardiovascular illnesses, North America is expected to account for a significant portion of the market for cardiac safety services during the forecasted period. The Asia Pacific market is expected to rise during the forecast period. A wide range of economic and social factors concludes the health system's financial arrangements and organizational structure influence the amount of money the region spends on healthcare and its growth rate over time. As the average person's disposable income rises, healthcare spending has increased in developed and developing nations. Cardiac safety services assist and design clinical studies & trials and other research necessary for the monitoring of heart safety. These are primarily concerned with tracking the complete cardiac safety profile through all clinical trial phases, from Phase I through Phase IV. These services include physiologic stress testing, platelet aggregation, non-invasive cardiac imaging, ambulatory blood pressure monitoring, and other services for insertion into the QT tests. Due to the assembling of services emphasizing end-to-end development, integrated services that offer cardiac safety services are generally favoured over standalone services due to the peculiarity of standalone services. All cardiovascular system components, including the blood vessels, heart, and blood constituents, are affected by cardiovascular safety liabilities, including cardiovascular and non-cardiovascular pharmaceuticals. Cardiovascular severe effects can be functional or structural and can happen after chronic treatment. The pharmaceutical industry has greatly benefited from the significant R&D activities performed at the clinical labs. Validation of the drug and designing a more effective drug are the leading factors responsible for adopting cardiac safety services in pharmaceutical and biopharmaceutical companies. The discovery and development of new medications for treating diseases rely heavily on clinical trials. It is the most effective technique for researchers to learn which therapies are effective or ineffective for people. Developing novel medications or medical devices to address diseases including cancer, endocrine, metabolic, and others is known as drug development. Therefore, clinical trials are the most efficient way to determine the therapeutic drug's safety and effectiveness before it is released onto the market and consumed by humans. This includes cardiac safety evaluation, a crucial step before releasing any medical product.

The market key players are Koninklijke Philips N.V., Laboratory Corporation of America Holdings, IQVIA, Medpace, and Ncardia.

In August 2023, Clarion (US) collaborated with Dr Vince Clinical Research (DVCR) (US). The strategic collaboration helps Clario (US) deliver accurate and cost-efficient cardiac safety data in the early clinical development stages.

In October 2022, IQVIA (US) launched its first self-collection safety lab panel for US clinical trial participants by a leading global clinical trial laboratory.

Global Cardiac Safety Services Market report provides deep insight into the market's current and future state across various regions. The study comprehensively analyses the Cardiac Safety Services market by segmenting based on the Type (Integrated Service and standalone Service), Service Type (ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, and Other Service Types), End-User Industry (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Other End Users), and Geography (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa). The report examines the market drivers and restraints and the impact of COVID-19 on the market growth in detail. The study covers and includes emerging market trends, developments, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.